+499.5%
MRNA vs TCOM
-42.5%
+542.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | TCOM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.9% | -1.3% | -1.6% |
| 7D | +5.5% | -9.5% | +15.0% | +12.7% |
| 30D | +158.7% | -10.7% | +169.5% | +178.6% |
| 3M | +182.1% | -14.6% | +196.8% | +206.5% |
| 6M | +151.8% | -19.3% | +171.1% | +175.2% |
| YTD | +393.6% | -42.9% | +436.5% | +428.1% |
| 1Y | +499.5% | -43.8% | +543.3% | +552.7% |
| All | +499.5% | -42.5% | +542.0% | +552.7% |
Cumulative growth
Daily Returns
Daily percentage return beside TCOM.
Daily Out/Under-Performance
Portfolio return minus TCOM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TCOM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded TCOM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling